PVLA

Palvella Therapeutics

46 hedge funds and large institutions have $7.33M invested in Palvella Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

39% less capital invested

Capital invested by funds: $12M → $7.33M (-$4.7M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14K
Puts
$1K
Net Calls
Net Calls Change

Top Sellers

1 -$984K
2 -$23.3K
3 -$19.7K
4
Millennium Management
Millennium Management
New York
-$10.7K
5
UBS Group
UBS Group
Switzerland
-$6.73K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.75M
2
$1.78M
3
$318K
4
$217K
5
$194K
6
$189K
7
$174K
8
$165K
9
$139K
10
$137K
11
$44.3K
12
$40.6K
13
$30.3K
14
$20.1K
15
$18.7K
16
$16.1K
17
$16K
18
$7.45K
19
$7.27K
20
$7.22K
21
$7.11K
22
$6.3K
23
$5.46K
24
$5.46K
25
$4.12K